Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib.
about
Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active CompoundsAcquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expressionBrother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanisms.MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerAuramine O, an incense smoke ingredient, promotes lung cancer malignancy.Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells.Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance.EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
P2860
Q26747518-6A8BC83D-3080-45A5-A3D8-4AAD7DB0CEA3Q30365571-07DE6FAE-1076-426D-8DAF-E8A23C64BEA1Q36293822-02AF19CC-1DCA-408A-92D4-265B72BCD586Q37661508-D8DE163E-526C-4547-84D2-4EB50445B198Q37666880-A450901F-BAE9-4461-9BBA-57F83EF6C1BBQ38682189-71D6534F-ED57-4671-99E3-E10545353BB0Q38696753-E2F6B705-3065-4374-9BD6-62F77072D8EEQ38745430-E9A55F70-516A-4607-89B5-696F636752D1Q41552614-85A2AE8D-B614-45EA-9378-845F97D2E8F3Q47136661-16C1E2BE-48F2-4ADC-8B34-EB66495B1153Q47146662-E1C5FA09-7E63-4F33-B104-0FD925C8E547Q48102549-64B4E26D-9269-40B3-8F30-63F73950D58DQ49720695-31DBDF6E-A105-4E43-95B2-27D504ECBD4CQ52651786-972CAE0B-0A4A-4B79-B7BB-CFDF8B031220Q53698558-6004A52E-22F0-40A5-9C53-65202FF59D8CQ53702598-CCB33766-C008-4EBB-8145-617EA3AD7700Q57736167-EA47469E-1DE2-4316-B269-BA72608AE907
P2860
Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@ast
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@en
type
label
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@ast
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@en
prefLabel
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@ast
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@en
P2093
P2860
P50
P356
P1433
P1476
Acquisition of cancer stem cel ...... quired resistance to afatinib.
@en
P2093
Hiroaki Asano
Hiromasa Yamamoto
Ken Suzawa
Mototsugu Watanabe
Shinichi Toyooka
Shinichiro Miyoshi
Tomoaki Ohtsuka
Yuichiro Miyoshi
P2860
P304
P356
10.1111/CAS.12749
P577
2015-07-21T00:00:00Z